Bliss GVS Pharma Limited (NSE:BLISSGVS)
India flag India · Delayed Price · Currency is INR
226.00
-4.01 (-1.74%)
Feb 19, 2026, 3:30 PM IST

Bliss GVS Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Market Capitalization
24,32112,38611,7937,4217,97810,181
Market Cap Growth
47.44%5.03%58.92%-6.98%-21.63%-2.08%
Enterprise Value
23,19811,51111,4877,3147,89010,302
Last Close Price
230.01117.40112.0070.1675.5196.09
PE Ratio
22.2914.6915.6310.4753.0514.86
PS Ratio
2.801.531.530.991.071.76
PB Ratio
2.081.131.180.810.941.23
P/TBV Ratio
2.161.191.230.850.981.27
P/FCF Ratio
-41.5015.83-12.9818.56
P/OCF Ratio
-11.7011.4721.635.8915.92
EV/Sales Ratio
2.671.421.490.971.061.79
EV/EBITDA Ratio
16.799.427.776.316.779.88
EV/EBIT Ratio
21.5111.839.257.427.7911.52
EV/FCF Ratio
-38.5615.42-12.8318.78
Debt / Equity Ratio
0.050.080.100.110.130.15
Debt / EBITDA Ratio
0.380.700.660.870.921.14
Debt / FCF Ratio
-2.951.34-1.782.22
Net Debt / Equity Ratio
-0.13-0.05-0.040.04-0.030.07
Net Debt / EBITDA Ratio
-1.11-0.44-0.270.29-0.220.58
Net Debt / FCF Ratio
--1.78-0.54-0.56-0.421.10
Asset Turnover
-0.650.650.660.680.55
Inventory Turnover
-3.533.623.643.623.90
Quick Ratio
-3.453.552.382.322.66
Current Ratio
-4.815.153.613.333.76
Return on Equity (ROE)
-8.62%8.50%8.70%2.76%9.37%
Return on Assets (ROA)
-4.84%6.56%5.44%5.79%5.31%
Return on Invested Capital (ROIC)
7.19%6.98%9.06%8.05%5.06%7.37%
Return on Capital Employed (ROCE)
-8.60%11.80%10.20%11.60%10.20%
Earnings Yield
4.49%6.81%6.40%9.55%1.88%6.73%
FCF Yield
-2.41%6.32%-8.02%7.71%5.39%
Dividend Yield
0.43%0.43%0.45%0.71%0.66%0.52%
Payout Ratio
-6.46%7.15%7.67%35.41%8.10%
Buyback Yield / Dilution
-1.06%0.04%-0.56%-0.26%0.26%-2.26%
Total Shareholder Return
-0.62%0.46%-0.12%0.45%0.92%-1.74%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.